Urology Trials

  • 30/09/2022


    A Phase III Randomized Open-Label Multi-Center Global Study of Durvalumab and Bacillus Calmette-Guerin (BCG) Administered as Combination Therapy Versus BCG Alone in High-Risk BCG-Naïve Non-Muscle-Invasive Bladder Cancer Patients (POTOMAC)

    View Trial
  • VT U CAN

    Venous Thromboembolism in muscle invasive locally advanced or metastatic urothelial cancer with or without chemotherapy

    View Trial
  • 31/12/2022


    BladderPath: Image Directed Redesign of Bladder Cancer Treatment Pathways

    View Trial
  • 29/04/2016


    Partnership in Prostate Cancer Care: the feasibility of an integrated system to improve patient outcomes and experience (ICARE-P)

    View Trial
  • 31/12/2020


    A Phase I Clinical Trial of a replication defective Ad5 vector expressing nitroreductase and GMCSF (AdNRGM) given via brachytherapy followed by CB1954 in patients with locally relapsed Prostate Cancer.

    View Trial
  • 31/12/2018

    Life after prostate cancer diagnosis

    View Trial